Research programme: periodontitis therapy - Camurus

Drug Profile

Research programme: periodontitis therapy - Camurus

Alternative Names: CAM 2031

Latest Information Update: 26 May 2010

Price : $50

At a glance

  • Originator Camurus
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Periodontal disorders

Most Recent Events

  • 26 May 2010 Discontinued - Preclinical for Periodontal disorders in Sweden (PO)
  • 08 May 2006 This programme is still in active development
  • 24 Aug 2005 Preclinical trials in Periodontal disorders in Sweden (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top